You are not currently logged in.
Access JSTOR through your library or other institution:
If You Use a Screen ReaderThis content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Mouse Model of OPRM1 (A118G) Polymorphism Has Sex-Specific Effects on Drug-Mediated Behavior
Stephen D. Mague, Carolina Isiegas, Peng Huang, Lee-Yuan Liu-Chen, Caryn Lerman, Julie A. Blendy and Solomon H. Snyder
Proceedings of the National Academy of Sciences of the United States of America
Vol. 106, No. 26 (Jun. 30, 2009), pp. 10847-10852
Published by: National Academy of Sciences
Stable URL: http://www.jstor.org/stable/40483641
Page Count: 6
You can always find the topics here!Topics: Morphine, Receptors, Genotypes, Female animals, Opioid receptors, Analgesia, Messenger RNA, Alcohols, Pain, Sensitization
Were these topics helpful?See something inaccurate? Let us know!
Select the topics that are inaccurate.
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Preview not available
A single nucleotide polymorphism (SNP) in the human µ-opioid receptor gene (OPRM1 A118G) has been widely studied for its association in a variety of drug addiction and pain sensitivity phenotypes; however, the extent of these adaptations and the mechanisms underlying these associations remain elusive. To clarify the functional mechanisms linking the OPRM1 A118G SNP to addiction and analgesia phenotypes, we derived a mouse model possessing the equivalent nucleotide/amino acid substitution in the Oprmi gene. Mice harboring this SNP (A112G) demonstrated several phenotypic similarities to humans carrying the A118G SNP, including reduced mRNA expression and morphine-mediated antinociception. We found additional phenotypes associated with this SNP including significant reductions of receptor protein levels, morphine-mediated hyperactivity, and the development of locomotor sensitization in mice harboring the G112 allele. In addition, we found sex-specific reductions in the rewarding properties of morphine and the aversive components of naloxone-precipitated morphine withdrawal. Further cross-species analysis will allow us to investigate mechanisms and adaptations present in humans carrying this SNP.
Proceedings of the National Academy of Sciences of the United States of America © 2009 National Academy of Sciences